Insmed Inc. buy Royal Bank of Canada
Start price
25.02.25
/
50%
€76.00
Target price
25.02.26
€95.22
Performance (%)
46.05%
Price
07:32
?
Summary
This prediction is currently active. The BUY prediction by Royal_Bank_of_Canada for Insmed Inc. has seen massive gains of 46.05%. This prediction currently runs until 25.02.26. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Insmed Inc. | 12.766% | 12.766% |
iShares Core DAX® | 0.998% | 0.948% |
iShares Nasdaq 100 | 1.965% | 4.491% |
iShares Nikkei 225® | 4.258% | 8.018% |
iShares S&P 500 | 2.037% | 3.420% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Insmed Inc. diskutieren
Insmed Incorporated (NASDAQ: INSM) is now covered by analysts at Royal Bank of Canada. They set an "outperform" rating and a $100.00 price target on the stock.
Ratings data for INSM provided by MarketBeat